AFT Pharmaceuticals targets Chinese consumers with Crystaderm launch

AFT Pharmaceuticals targets Chinese consumers with Crystaderm launch
AFT's Chinese licensee Hainan Haiyao is doing the groundwork for its China launch. (Image: AFT)
Rebecca Stevenson
AFT Pharmaceuticals' Chinese licensee is ramping up efforts to promote its first aid cream Crystaderm to Chinese consumers. Chinese firm Hainan Haiyao Co will get its first shipment of Crystaderm at the end of this calendar year.  AFT Pharmaceuticals co-founder and managing director Dr Hartley Atkinson said the Chinese company was laying the groundwork for the product launch now. Atkinson said Shenzhen Stock Exchange-listed Hainan Haiyao had representatives meeting with doctors to raise awareness of the New Zealand produ...

More Markets

Drury’s ASX stag, MetroGlass’s new owner, and more
Markets Small Cap Wrap

Drury’s ASX stag, MetroGlass’s new owner, and more

Rod Drury goes ‘pre-revenue’ again, plus small cap news from NZ.

Listed property firms welcome ‘Investment Boost'
Property

Listed property firms welcome ‘Investment Boost'

The tax policy could translate into millions in extra cash.

NZX down as property company gets key renewal
Markets Market Close

NZX down as property company gets key renewal

ASB Bank has extended the lease for its downtown Auckland site for another nine years.

Tom Raynel 03 Jul 2025
Anna Scott joining Mercer
Markets

Anna Scott joining Mercer

Former Smart boss will replace current Mercer chief executive Martin Lewington.

Staff reporters 03 Jul 2025